ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  2009-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00280-008-0783-xPMID 18575867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA Repair by ERCC1 in Non-Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

  2010cited by this paper
• A Gynecologic Oncology Group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy.

  2007cited by this paper
• DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

  2006cited by this paper
• Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells

  2006influential reference
• The Intricacies of p21 Phosphorylation: Protein/Protein Interactions, Subcellular Localization and Stability

  2006cited by this paper
• Surviving the breakup: the DNA damage checkpoint.

  2006cited by this paper
• RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.

  2006cited by this paper
• Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases.

  2006cited by this paper
• Similar chromosomal changes in cisplatin and oxaliplatin‐resistant sublines of the H69 SCLC cell line are not associated with platinum resistance

  2006influential reference
• Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells

  2005cited by this paper
• Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.

  2005cited by this paper
• ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapy.

  2005cited by this paper
• Combined GADD45A and Thymidine Phosphorylase Expression Levels Predict Response and Survival of Neoadjuvant-Treated Gastric Cancer Patients

  2005cited by this paper
• Differential and collaborative actions of Rad51 paralog proteins in cellular response to DNA damage

  2005cited by this paper
• Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin.

  2005cited by this paper
• Excision repair cross complementing-group 1: gene expression and platinum resistance.

  2004cited by this paper
• Gene Expression as a Predictive Marker of Outcome in Stage IIB-IIIA-IIIB Non-Small Cell Lung Cancer After Induction Gemcitabine-Based Chemotherapy Followed By Resectional Surgery

  2004cited by this paper
• Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.

  2004cited by this paper
• Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability

  2004cited by this paper
• Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle

  2003cited by this paper
• Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.

  2003cited by this paper
• Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression.

  2002cited by this paper
• Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells.

  2002cited by this paper
• Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

  2002cited by this paper
• Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis.

  2002cited by this paper
• Exogenous expression of p21(WAF1/CIP1) exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells.

  2001cited by this paper
• Nucleotide excision repair gene (ERCC1) deficiency causes G2 arrest in hepatocytes and a reduction in liver binucleation: the role of p53 and p21

  2000cited by this paper
• A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.

  2000cited by this paper
• Role of the nucleotide excision repair gene ERCC1 in formation of recombination-dependent rearrangements in mammalian cells.

  2000cited by this paper
• Primer3 on the WWW for general users and for biologist programmers.

  2000cited by this paper
• The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells.

  2000cited by this paper
• The Rad51 Paralog Rad51B Promotes Homologous Recombinational Repair

  2000cited by this paper
• HsRec2/Rad51L1, a protein influencing cell cycle progression, has protein kinase activity.

  2000cited by this paper
• Acquisition of chemoresistance in a human ovarian carcinoma cell line is linked to a defect in cell cycle control

  1998cited by this paper
• Myc and the cell cycle.

  1998cited by this paper
• BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II).

  1998cited by this paper
• The human REC2/RAD51B gene acts as a DNA damage sensor by inducing G1 delay and hypersensitivity to ultraviolet irradiation.

  1998cited by this paper
• Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell lines.

  1998cited by this paper
• Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination.

  1998cited by this paper
• Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence.

  1997cited by this paper
• Repair defect in p21WAF1/CIP1 -/- human cancer cells

  1996cited by this paper
• Repair Defect in p21 WAF1/CIP1 -/- human cancer cells.

  1996cited by this paper
• Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.

  1994cited by this paper
• Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment.

  1994cited by this paper
• Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer.

  1991cited by this paper
• Mutants of the Five Rad51 Paralogs Recombinational Repair in Knockout Chromosome Instability and Defective

  year unknowncited by this paper

• Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas.

  2019cites this paper
• Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines

  2019cites this paper
• Activity profile of the cisplatin analogue PN149 in different tumor cell lines

  2018cites this paper
• Cisplatin resistance in cell models: evaluation of metallomic and biological predictive biomarkers to address early therapy failure.

  2017cites this paper
• A molecular assembly that crawls on a solid substrate with a metabolic-like process

  2016cites this paper
• Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance

  2015cites this paper
• A miR-590/Acvr2a/Rad51b Axis Regulates DNA Damage Repair during mESC Proliferation

  2014cites this paper
• RAD51B Activity and Cell Cycle Regulation in Response to DNA Damage in Breast Cancer Cell Lines

  2014cites this paper
• Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells.

  2011cites this paper
• Regrowth Resistance: Low-Level Platinum Resistance Mediated by Rapid Recovery from Platinum-Induced Cell-Cycle Arrest

  2009cites this paper
• FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Sciences

  2008cites this paper
• Functional analysis of the Rad51d (E233G) breast cancer associated polymorphism and a pharmacogenetic evaluation of RAD51D status

  2008cites this paper
• VU Research Portal Molecular aspects of 5-Fluorouracil and Oxaliplatin activity

  year unknowncites this paper